Elsasser-Beile, U., Willenbacher, W., Bartsch, H. H., Gallati, H., Schulte, Monting J., and von, Kleist S. Cytokine production in leukocyte cultures during therapy with Echinacea extract. J Clin Lab Anal. 1996;10(6):441-445. View abstract.
Gohla, S. H., Haubeck, H. D., Schrum, S., Soltau, H., and Neth, R. D. Activation of CD4-positive T cells by polysaccharide fractions isolated from the Cupressaceae Thuja occidentalis L. (Arborvitae). Haematol.Blood Transfus. 1989;32:268-272. View abstract.
Hauke, W., Kohler, G., Henneicke-von Zepelin, H. H., and Freudenstein, J. Esberitox N as supportive therapy when providing standard antibiotic treatment in subjects with a severe bacterial infection (acute exacerbation of chronic bronchitis). A multicentric, prospective, double-blind, placebo-controlled study. Chemotherapy 2002;48(5):259-266. View abstract.
Naser, B., Bodinet, C., Tegtmeier, M., and Lindequist, U. Thuja occidentalis (Arbor vitae): A Review of its Pharmaceutical, Pharmacological and Clinical Properties. Evid.Based Complement Alternat.Med 2005;2(1):69-78. View abstract.
Naser, B., Lund, B., Henneicke-von Zepelin, H. H., Kohler, G., Lehmacher, W., and Scaglione, F. A randomized, double-blind, placebo-controlled, clinical dose-response trial of an extract of Baptisia, Echinacea and Thuja for the treatment of patients with common cold. Phytomedicine. 2005;12(10):715-722. View abstract.
Singh, S. K., Shanmugavel, M., Kampasi, H., Singh, R., Mondhe, D. M., Rao, J. M., Adwankar, M. K., Saxena, A. K., and Qazi, G. N. Chemically standardized isolates from Cedrus deodara stem wood having anticancer activity. Planta Med 2007;73(6):519-526. View abstract.
Sunila, E. S. and Kuttan, G. A preliminary study on antimetastatic activity of Thuja occidentalis L. in mice model. Immunopharmacol.Immunotoxicol. 2006;28(2):269-280. View abstract.
Electronic Code of Federal Regulations. Title 21. Part 182 -- Substances Generally Recognized As Safe. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=182
Fetrow CW, Avila JR. Professional's Handbook of Complementary & Alternative Medicines. 1st ed. Springhouse, PA: Springhouse Corp., 1999.
Gohla SH, Haubeck HD, Neth RD. Mitogenic activity of high molecular polysaccharide fractions isolated from the Cupressaceae Thuja occidentale L. I. Macrophage-dependent induction of CD-4-positive T-helper (Th+) lymphocytes. Leukemia 1988;2:528-33. View abstract.
Henneicke-von Zepelin H, Hentschel C, Schnitker J, et al. Efficacy and safety of a fixed combination phytomedicine in the treatment of the common cold (acute viral respiratory tract infection): results of a randomised, double blind, placebo-controlled, multicentre study. Curr Med Res Opin 1999;15:214-27. View abstract.
Lust J. The herb book. New York, NY: Bantam Books, 1999.
Millet Y, Jouglard J, Steinmetz MD, et al. Toxicity of some essential plant oils. Clinical and experimental study. Clin Toxicol 1981;18:1485-98. View abstract.
Offergeld R, Reinecker C, Gumz E, et al. Mitogenic activity of high molecular polysaccharide fractions isolated from the cuppressaceae Thuja occidentalis L. enhanced cytokine-production by thyapolysaccharide, g-fraction (TPSg). Leukemia 1992;6(Suppl 3):189S-91S. View abstract.
Stafstrom CE. Seizures in a 7-month-old child after exposure to the essential plant oil thuja. Pediatr Neurol 2007;37:446-8. View abstract.